Abstract
Chronic respiratory diseases continue to be managed within fragmented specialty-based structures despite robust evidence supporting the “global airways” concept, which recognizes allergic rhinitis, chronic rhinosinusitis, and asthma as interconnected manifestations of a shared inflammatory continuum. Advances in endotype-driven classification, the treatable traits framework, and the cross-efficacy of biologic therapies have reinforced the scientific and therapeutic rationale for integrated care; however, implementation remains largely theoretical. This editorial advocates for the establishment of Global Airways Units (GAUs), a pragmatic, multidisciplinary model in which otolaryngologists, pulmonologists, and allergists jointly evaluate patients within a unified diagnostic and therapeutic framework. By aligning healthcare organization with established pathophysiological knowledge and evolving guideline recommendations, GAUs represent a feasible, cost-effective strategy to operationalize precision medicine across the entire airway spectrum and translate consensus into tangible clinical benefit.
Get full access to this article
View all access options for this article.